specialists. This article will provide a structured methodology, detailing objectives, documentation requirements, roles, and inspection expectations at each phase.

Step 1: Define the Scope of the QMS

The first step in developing a combined and companion QMS is to clearly define its scope. This involves identifying the specific medical devices and combination products that will be covered under the QMS.

Objectives: The primary objective is to ensure that the QMS encompasses all relevant processes, products, and regulatory requirements. This will facilitate compliance with FDA regulations, ISO 13485 standards, and other applicable guidelines.

Documentation: Key documents to prepare include a scope statement, product classifications, and a list of applicable regulations. For example, if your organization manufactures a drug-device combination product, you must consider both the FDA’s drug and device regulations.

Roles: Quality managers should lead this phase, collaborating with regulatory affairs and product development teams to ensure comprehensive coverage.

Inspection Expectations: During inspections, regulators will expect to see a well-defined scope that aligns with your product portfolio. Any discrepancies may lead to compliance issues.

Step 2: Establish Quality Objectives

Once the scope is defined, the next step is to establish quality objectives that align with the organization’s strategic goals and regulatory requirements.

Objectives: Quality objectives should be specific, measurable, achievable, relevant, and time-bound (SMART). For instance, a quality objective could be to reduce product defects by 20% within the next fiscal year.

Documentation: Document quality objectives in a quality manual or a separate quality objectives document. This should include metrics for measuring success and responsible parties for each objective.

Roles: Quality managers and senior management should collaborate to ensure that quality objectives are aligned with overall business goals.

Inspection Expectations: Inspectors will review quality objectives to ensure they are realistic and aligned with regulatory requirements. They will also assess whether the organization has a system in place to monitor and report on these objectives.

Step 3: Develop QMS Processes

The next phase involves developing the processes that will make up the QMS. This includes defining procedures for document control, design control, risk management, and post-market surveillance.

Objectives: The goal is to create a robust framework that ensures product quality and compliance throughout the product lifecycle.

Documentation: Key documents include process maps, standard operating procedures (SOPs), and risk management plans. For example, a design control process should outline how design inputs are translated into outputs while managing risks associated with the product.

Roles: Cross-functional teams, including R&D, manufacturing, and quality assurance, should be involved in developing these processes to ensure comprehensive coverage.

Inspection Expectations: Inspectors will evaluate the adequacy of QMS processes during audits. They will look for evidence of effective implementation and adherence to documented procedures.

Step 4: Implement Training Programs

Training is a critical component of a successful QMS. Employees must be adequately trained on the processes, procedures, and regulatory requirements relevant to their roles.

Objectives: The objective is to ensure that all personnel are competent and aware of their responsibilities within the QMS.

Documentation: Develop a training plan that includes training materials, schedules, and records of completed training. For example, training records should detail who was trained, on what topics, and when.

Roles: Quality managers should oversee the training program, while department heads are responsible for ensuring their teams are trained appropriately.

Inspection Expectations: Inspectors will review training records to verify that personnel are adequately trained and competent in their roles. They may also conduct interviews to assess knowledge and understanding of QMS processes.

Step 5: Conduct Internal Audits

Internal audits are essential for assessing the effectiveness of the QMS and identifying areas for improvement. This step should be conducted regularly to ensure ongoing compliance.

Objectives: The primary objective is to evaluate the QMS against established processes and regulatory requirements, identifying non-conformities and opportunities for improvement.

Documentation: Audit plans, checklists, and reports should be documented. For example, an audit report should detail findings, corrective actions, and timelines for resolution.

Roles: Internal auditors, who should be independent of the processes being audited, will conduct the audits. Quality managers will oversee the audit process and follow up on corrective actions.

Inspection Expectations: Inspectors will review internal audit reports and corrective action plans to ensure that non-conformities are addressed promptly and effectively.

Step 6: Manage Non-Conformities and CAPA

Managing non-conformities and implementing corrective and preventive actions (CAPA) is crucial for maintaining compliance and improving the QMS.

Objectives: The objective is to identify root causes of non-conformities and implement effective corrective actions to prevent recurrence.

Documentation: Maintain a CAPA log that includes details of non-conformities, root cause analyses, and actions taken. For example, if a product defect is identified, the CAPA process should document the investigation and resolution steps.

Roles: Quality managers should lead the CAPA process, while cross-functional teams may be involved in root cause analysis and action implementation.

Inspection Expectations: Inspectors will review CAPA documentation to assess the effectiveness of the process and ensure that corrective actions are implemented in a timely manner.

Step 7: Monitor and Measure QMS Performance

Monitoring and measuring QMS performance is essential for ensuring continuous improvement and compliance with regulatory requirements.

Objectives: The objective is to establish metrics and key performance indicators (KPIs) to evaluate the effectiveness of the QMS.

Documentation: Develop a performance monitoring plan that outlines the metrics to be tracked, such as defect rates, audit findings, and training completion rates.

Roles: Quality managers should oversee the monitoring process, while department heads should be responsible for tracking performance within their areas.

Inspection Expectations: Inspectors will review performance data to assess the effectiveness of the QMS and the organization’s commitment to continuous improvement.

Step 8: Review and Update the QMS

The final step in establishing a combined and companion QMS is to conduct regular management reviews and updates to ensure ongoing compliance and effectiveness.

Objectives: The objective is to evaluate the overall performance of the QMS and make necessary adjustments based on internal audits, performance data, and regulatory changes.

Documentation: Document management review meetings, including agendas, attendees, and action items. For example, a management review report should summarize findings and decisions made during the review.

Roles: Senior management should lead the review process, with input from quality managers and department heads.

Inspection Expectations: Inspectors will expect to see evidence of regular management reviews and updates to the QMS, demonstrating a commitment to continuous improvement and compliance.

Conclusion

Establishing a combined and companion QMS for medical devices and combination products is a complex but essential process for organizations operating in regulated environments. By following this step-by-step guide, quality managers, regulatory affairs professionals, and compliance specialists can develop a robust QMS that meets the requirements of the US FDA, EMA, and MHRA, while adhering to ISO standards.

Implementing a comprehensive QMS not only ensures compliance but also enhances product quality and patient safety, ultimately leading to better outcomes for both organizations and their customers.